Female Fertility And Pregnancy Rapid Test Market Report 2026

Female Fertility And Pregnancy Rapid Test Market Overview

• Female Fertility And Pregnancy Rapid Test market size has reached to $1.48 billion in 2025 • Expected to grow to $2.05 billion in 2030 at a compound annual growth rate (CAGR) of 6.7% • Growth Driver: Rising Incidence Of Gynecological Disorders Fuels Growth In The Female Fertility And Pregnancy Rapid Test Market • Market Trend: Innovation Accelerates In Female Fertility & Pregnancy Rapid Test Market With Launch Of First Saliva Pregnancy Self-Test • North America was the largest region in 2025.

What Is Covered Under Female Fertility And Pregnancy Rapid Test Market?

The female fertility and pregnancy rapid tests refer to a method used to test fertility and pregnancy in women by performing drugstore-bought urine tests and blood tests at the doctor's office. Rapid test kits for fertility and pregnancy are a simple, user-friendly fertility testing solution used for the detection of ovulation and/or for diagnosing infertility in females. The main products for female fertility and pregnancy rapid tests are fertility rapid test kits and pregnancy rapid test kits. Fertility rapid tests refer to in vitro diagnostic tools that allow qualitative identification and assessment of pregnancy, the fertility cycle, ovulation, and sperm counts in a matter of minutes. The various devices include digital devices, and line-indicator devices, which are used for various tests such as FSH urine test, LH urine test, HCG blood testing, and HCG urine testing. They are sold by various distribution channels including hospital channels, retail channels, and online channels.

What Is The Female Fertility And Pregnancy Rapid Test Market Growth Forecast?

The female fertility and pregnancy rapid test market size is expected to see strong growth in the next few years. It will grow to $2.05 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing demand for early pregnancy detection, rising adoption of digital health monitoring solutions, growing focus on personalized fertility management, expansion of telehealth-supported diagnostics, increasing penetration of e-commerce healthcare products. Major trends in the forecast period include increasing adoption of at-home rapid testing kits, rising demand for digital and app-connected test devices, growing use of combo fertility and pregnancy tests, expansion of online distribution channels, enhanced focus on user-friendly and accurate test designs.

Global Female Fertility And Pregnancy Rapid Test Market Segmentation

1) By Product: Fertility Rapid Test Kits, Pregnancy Rapid Test Kits 2) By Device Type: Digital Devices, Line-indicator Devices 3) By Test Type: FSH Urine Test, LH Urine Test, hCG Blood Test, hCG Urine Test 4) By Distribution Channel: Hospital Channel, Retail Channel, Online Channel Subsegments: 1) By Fertility Rapid Test Kits: Ovulation Predictor Kits, Luteinizing Hormone (LH) Test Kits, Follicle-Stimulating Hormone (FSH) Test Kits 2) By Pregnancy Rapid Test Kits: Urine-Based Pregnancy Tests, Blood-Based Pregnancy Tests, Combo Fertility And Pregnancy Tests

What Is The Driver Of The Female Fertility And Pregnancy Rapid Test Market?

The increasing incidence of gynecological disorders is expected to propel the growth of the female fertility and pregnancy rapid test market going forward. A gynecological problem is a medical ailment that affects the female reproductive organs, specifically the breasts and abdominal and pelvic organs such as the womb (uterus), ovaries, vagina, fallopian tubes, and vulva. Female fertility and pregnancy a rapid test helps gynecological disorders by enabling early detection of hormonal imbalances or pregnancy-related issues, supporting timely diagnosis and effective management of reproductive health conditions. For instance, in May 2025, according to a report published by the National Library of Medicine, a US-based government organization, about 61.2% of women experienced at least one gynecological morbidity, with dysmenorrhea being the most common (61.3%), followed by irregular menses (36.1%) and infertility (36.1%). Therefore, the increasing incidence of gynecological disorders is driving the growth of the female fertility and pregnancy rapid test industry.

Key Players In The Global Female Fertility And Pregnancy Rapid Test Market

Major companies operating in the female fertility and pregnancy rapid test market are Abbott Laboratories, Atlas Medical GmbH, bioMérieux SA, Church & Dwight Co. Inc., Quidel Corporation, Egens Group, Eurofins Scientific SE, Everlywell Inc., Genea Pty Limited, Geratherm Medical AG, SA Scientific Ltd., Artron Laboratories Inc., PRIMA Lab SA, The Procter & Gamble Company, Alere Inc., Prestige Brands Holdings Inc., SPD Swiss Precision Diagnostics GmbH, Fairhaven Health LLC, Fertility Focus Limited, HiLin Life Products Inc., Inverness Medical Innovations Inc., UEBE Medical GmbH, Wondfo Biotech Co. Ltd.

Global Female Fertility And Pregnancy Rapid Test Market Trends and Insights

Major companies operating in the female fertility and pregnancy rapid test market are focusing on developing innovative solutions, such as saliva-based home pregnancy tests, to meet the rising demand for non-invasive. A saliva-based pregnancy test is a lateral-flow, point-of-care assay that detects pregnancy biomarkers in oral fluid rather than urine. For Instance, in May 2024, Abingdon Health plc, a UK-based lateral flow CDMO, launched world’s first Boots-branded saliva pregnancy self-test (available in Boots stores and online), bringing this saliva-based technology into mainstream retail. The product is composed of a saliva collection interface and a proprietary lateral-flow immunoassay developed with Salignostics and Crest Medical, designed to bind and indicate the presence of the pregnancy biomarker in oral fluid; it functions as a rapid single-use self-test that gives a result within minutes and is packaged for OTC sale. It uniquely removes urine collection from the testing workflow (improving comfort and hygiene), supports consumer adoption through a familiar “stick/cassette” format, and is intended for routine home screening and early confirmation of pregnancy, with the added retail reach and consumer trust of Boots.

What Are Latest Mergers And Acquisitions In The Female Fertility And Pregnancy Rapid Test Market?

In July 2023, Quest Diagnostics Incorporated, a U.S.-based healthcare diagnostics company, partnered with Proov Inc. With this partnership, Quest Diagnostics Incorporated aimed to expand its consumer-initiated testing portfolio and broaden access to at-home fertility testing by offering Proov’s FDA-cleared Proov Confirm PdG home test through questhealth.com. Proov Inc., is a US-based health technology company that specializes in at-home PdG (pregnanediol glucuronide) urine tests and companion digital tools to help women confirm successful ovulation.

Regional Outlook

North America was the largest region in the female fertility and pregnancy rapid test market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Female Fertility And Pregnancy Rapid Test Market?

The female fertility and pregnancy rapid test market consists of sales of urine and blood test kits used to detect female pregnancy and fertility. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.